Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 10, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.3K

Cholangiocarcinoma.

Alyssa M Krasinskas1

  • 1Department of Pathology and Laboratory Medicine, Emory University Hospital, 1364 Clifton Road Northeast, Suite H180D, Atlanta, GA 30322, USA.

Surgical Pathology Clinics
|May 13, 2018
PubMed
Summary

This review details cholangiocarcinoma (bile duct cancer), covering intrahepatic and extrahepatic types. It explores classifications, differences, precursor lesions, and emerging targeted therapies for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.

Cancer research·2025
Same author

Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancer.

NPJ precision oncology·2025
Same author

Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma.

Hepatology (Baltimore, Md.)·2025
Same author

Augmented reality microscopy to bridge trust between AI and pathologists.

NPJ precision oncology·2025
Same author

Diagnostic Pearls and Pitfalls in the Evaluation of Small Biopsies From the Bile Duct and Ampulla.

Archives of pathology & laboratory medicine·2024
Same author

ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.

Annals of surgical oncology·2024

Area of Science:

  • Oncology
  • Gastroenterology
  • Pathology

Background:

  • Cholangiocarcinoma is a rare but aggressive cancer originating from the bile ducts.
  • It presents as intrahepatic (within the liver) or extrahepatic (outside the liver) forms, each with distinct characteristics.

Purpose of the Study:

  • To provide a comprehensive overview of cholangiocarcinoma.
  • To outline current classification systems and discuss clinicopathologic, immunohistochemical, and molecular distinctions.
  • To review precursor lesions, prognosis, treatment strategies, and novel targeted therapies.

Main Methods:

  • Literature review and synthesis of existing research on cholangiocarcinoma.
  • Analysis of classification schemes based on anatomy, morphology, and cellular origin.
  • Comparison of molecular and immunohistochemical profiles between different cholangiocarcinoma subtypes.

Main Results:

  • Multiple classification systems exist for cholangiocarcinoma, based on diverse criteria.
  • Significant clinicopathologic, immunohistochemical, and molecular differences are observed between intrahepatic and extrahepatic cholangiocarcinoma.
  • Intrahepatic cholangiocarcinoma exhibits distinct subtypes with unique features.

Conclusions:

  • Accurate classification is crucial for understanding cholangiocarcinoma heterogeneity.
  • Recognizing the differences between subtypes aids in targeted treatment selection.
  • Ongoing research into precursor lesions and targeted therapies offers hope for improved cholangiocarcinoma management.
Keywords:
Bile ductCholangiocarcinomaExtrahepaticIDH1IDH2Intrahepatic

More Related Videos

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

818
Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

41.5K

Related Experiment Videos

Last Updated: Feb 10, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.3K
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

818
Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

41.5K